DRUGS /MEDICATIONS Flashcards
(3 cards)
anti-obesity medication was taken off the market due to an increased incidence of cancer compared to those taking placebo
Lorcaserin was approved by the FDA for chronic weight management in 2012 and taken off the market in 2020. RCTs for lorcaserin showed placebo-subtracted weight loss of 3.6% and 3.0%. However, post-marketing cardiovascular outcome trial showed that more patients taking lorcaserin (7.7%) were diagnosed with cancer compared to those taking placebo (7.1%). A range of cancer types was reported, with several different types of cancer occurring more frequently in the lorcaserin group, including pancreatic, colorectal, and lung.
was found to reduce postprandial glycemic excursions in individuals with Type 1 or Type 2 DM taking insulin, slows gastric emptying, and suppresses glucagon?
Pramlintide
